Markets:

Overview

News

Currencies

International

Treasuries

Azenta, Inc. - Common Stock (NQ:AZTA)

21.42 +0.05 (+0.23%)

Streaming Delayed Price Updated: 4:00 PM EDT, Mar 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Azenta, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

A Look Back at Drug Development Inputs & Services Stocks’ Q4 Earnings: Repligen (NASDAQ:RGEN) Vs The Rest Of The Pack

March 11, 2025

As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the drug development inputs & services industry, including Repligen (NASDAQ:RGEN) and...

Via StockStory

Spotting Winners: Charles River Laboratories (NYSE:CRL) And Drug Development Inputs & Services Stocks In Q4

March 05, 2025

Looking back on drug development inputs & services stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including Charles River Laboratories (NYSE:CRL) and its peers.

Via StockStory

What To Expect From Fortrea’s (FTRE) Q4 Earnings

March 02, 2025

Clinical research company Fortrea Holdings (NASDAQ:FTRE) will be reporting earnings tomorrow before market hours. Here’s what investors should know.

Via StockStory

UFP Technologies (UFPT) Reports Q4: Everything You Need To Know Ahead Of Earnings

February 24, 2025

Medical products company UFP Technologies (NASDAQ:UFPT) will be announcing earnings results tomorrow morning. Here’s what to look for.

Via StockStory

A Glimpse Into The Expert Outlook On Azenta Through 4 Analysts ↗

February 06, 2025

Via Benzinga

Earnings Scheduled For February 5, 2025 ↗

February 05, 2025

Via Benzinga

Earnings Scheduled For November 12, 2024 ↗

November 12, 2024

Via Benzinga

A Look Ahead: Azenta's Earnings Forecast ↗

November 11, 2024

Via Benzinga

Decoding 5 Analyst Evaluations For Azenta ↗

July 02, 2024

Via Benzinga

Earnings To Watch: Repligen (RGEN) Reports Q4 Results Tomorrow

February 19, 2025

Biopharma manufacturing company Repligen Corporation (NASDAQ:RGEN) will be announcing earnings results tomorrow morning. Here’s what you need to know.

Via StockStory

Earnings To Watch: Charles River Laboratories (CRL) Reports Q4 Results Tomorrow

February 18, 2025

Lab services company Charles River Laboratories (NYSE:CRL) will be reporting earnings tomorrow before the bell. Here’s what investors should know.

Via StockStory

West Pharmaceutical Services (WST) Q4 Earnings Report Preview: What To Look For

February 12, 2025

Healthcare products company West Pharmaceutical Services (NYSE:WST) will be reporting earnings tomorrow morning. Here’s what to look for.

Via StockStory

Medpace (MEDP) To Report Earnings Tomorrow: Here Is What To Expect

February 09, 2025

Clinical research company Medpace Holdings (NASDAQ:MEDP) will be announcing earnings results tomorrow after market hours. Here’s what to expect.

Via StockStory

Azenta’s (NASDAQ:AZTA) Q4 Sales Top Estimates

February 05, 2025

Life sciences company Azenta (NASDAQ:AZTA) reported revenue ahead of Wall Street’s expectations in Q4 CY2024, but sales fell by 4.4% year on year to $147.5 million. Its non-GAAP profit of $0.05 per...

Via StockStory

The Analyst Landscape: 7 Takes On Azenta ↗

May 09, 2024

Via Benzinga

Decoding 7 Analyst Evaluations For Azenta ↗

March 28, 2024

Via Benzinga

Stocks Rebound, Google Eyes Worst Drop In A Year, Gold Shatters Fresh Records: What's Driving Markets Wednesday? ↗

February 05, 2025

Wall Street rose on Wednesday, with all major equity indices advancing as investors assessed the latest batch of corporate earnings and drew optimism from positive labor market data.

Via Benzinga

In-Depth Examination Of 5 Analyst Recommendations For Azenta ↗

March 07, 2024

Via Benzinga

Azenta: Q1 Earnings Insights ↗

February 07, 2024

Via Benzinga

Earnings Scheduled For February 7, 2024 ↗

February 07, 2024

Companies Reporting Before The Bell • Madison Square Garden (NYSE:MSGE) is expected to report quarterly loss at $0.80 per share on revenue of $301.83 million.

Via Benzinga

Preview: Azenta's Earnings ↗

February 06, 2024

Via Benzinga

Illumina (ILMN) Reports Earnings Tomorrow: What To Expect

February 05, 2025

Genomics company Illumina (NASDAQ:ILMN) will be reporting results tomorrow after the bell. Here’s what investors should know.

Via StockStory

IQVIA (IQV) Q4 Earnings Report Preview: What To Look For

February 05, 2025

Clinical research company IQVIA (NYSE: IQV) will be announcing earnings results tomorrow before market hours. Here’s what to look for.

Via StockStory

Quantum Computing, BlackBerry And Lucid Group Are Among Top Mid Cap Gainers Last Week (December 16-20): Are The Others In Your Portfolio? ↗

December 22, 2024

The top nine mid-cap stocks from the last week are: Quantum Computing Inc., BlackBerry Limited, IonQ, Inc., Rigetti Computing, Inc., SoundHound AI, Inc., Xometry, Inc., Lucid Group, Inc., Oklo Inc.,...

Via Benzinga

Topics Artificial Intelligence

Williams-Sonoma, Wix.com, Dolby Laboratories And Other Big Stocks Moving Higher On Wednesday ↗

November 20, 2024

Via Benzinga

A Glimpse Into The Expert Outlook On Azenta Through 4 Analysts ↗

February 01, 2024

Via Benzinga

AZTA Stock Earnings: Azenta Beats EPS, Beats Revenue for Q3 2024 ↗

August 06, 2024

AZTA stock results show that Azenta beat analyst estimates for earnings per share and beat on revenue for the third quarter of 2024.

Via InvestorPlace

Stock Market Crash Warning: Don’t Get Caught Holding These 3 Robotics Stocks ↗

May 14, 2024

Despite the promises of the robotics industry, there are key robotics stocks to sell as the market remains volatile.

Via InvestorPlace

AZTA Stock Earnings: Azenta Beats EPS, Misses Revenue for Q2 2024 ↗

May 08, 2024

AZTA stock results show that Azenta beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.

Via InvestorPlace

5 medical stocks growing earnings by triple digits

February 06, 2024

There is a little known way to pick stocks like the pros do, and today's exercise points you to five high-probability winners in a sector that's quickly turning

Via MarketBeat

Topics Economy

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.